A US based clinical-stage biopharmaceutical company was looking for tailored stock throughput cover across their operations.
The insured’s needs
The biopharmaceutical company needed complete coverage for transit and stock exposures across their supply chain. This included manufacturing, storage as inventory and distribution across the US and export into Europe.
Working with Lloyd’s markets, we were able to offer seamless coverage tailored to the insured’s particular needs and distribution model.
Competing directly with a local specialist pharmaceutical MGA insurer, our personalised coverage also offered significant premiums savings.